Latest filing published 12 Aug 2021 for Adagio Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Mithril II LP: trading record in brief
All filings by Mithril II LP on record concern Invivyd, Inc. The record holds 2 filings, all for trades on 10 August 2021.
The open-market record is one-sided, with 1 purchase worth €29.0M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 12 August 2021: an open-market purchase of €29.0M, in Invivyd, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mithril II LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,244,580 sharesCommon StockSEC:0001209191-21-051298:0
1 of 1 declaration
